Effectiveness of Opicapone in Parkinson's according to baseline use of dopamine agonists: the real-world OPTIPARK study

被引：0
|
作者：
Jost, W. [1 ]
Reichmann, H. [2 ]
Lees, A. [3 ]
Marinho, D. [4 ]
Magalhaes, D. [4 ]
Rocha, J. F. [4 ]
Soares-da-Silva, P. [4 ]
机构：
[1] Parkinson Klin Ortenau, Wolfach, Germany
[2] Univ Dresden, Dept Neurol, Dresden, Germany
[3] Natl Hosp Neurol & Neurosurg, Dept Clin & Movement Neurosci, London, England
[4] BIAL Portela & Ca SA, Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
MOTOR FLUCTUATIONS; LEVODOPA; DISEASE; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-747
引用
收藏
页码：905 / 905
页数：1
相关论文
共 50 条
  • [1] Effectiveness of Opicapone in Parkinson's according to baseline use of safinamide: the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 321 - 321
  • [2] Effectiveness of Opicapone in Parkinson's according to baseline use of entacapone: the real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 383 - 383
  • [3] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of dopamine agonists: Findings from the real-world OPTIPARK study
    Jost, Wolfgang
    Reichmann, Heinz
    Lees, Andrew
    Marinho, Daniela
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 272 - 272
  • [4] Effectiveness of Opicapone in Parkinson's according to baseline use of MAO-B inhibitors & DA: real-world OPTIPARK study
    Reichmann, H.
    Warnecke, T.
    Lees, A.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 352 - 353
  • [5] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of monoamine-oxidase-b inhibitors and dopamine agonists: The real-world OPTIPARK study
    Reichmann, Heinz
    Warnecke, Tobias
    Lees, Andrew
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 272 - 273
  • [6] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: Findings from the real-world OPTIPARK study
    Pavese, Nicola
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 268 - 269
  • [7] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: Findings from the real-world OPTIPARK study
    Jost, Wolfgang
    Reichmann, Heinz
    Lees, Andrew
    Marinho, Daniela
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 276 - 276
  • [8] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: findings from the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S228 - S229
  • [9] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: findings from the real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S214 - S214
  • [10] Influence of disease duration in the Opicapone effectiveness in Parkinson's patients: real-world OPTIPARK study
    Warnecke, T.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 904 - 904
12345